Patent CN112220919A, filed 2020-09-27 -
Application filed by Shanghai National Engineering Research
Center for Nanotechnology Co Ltd. Status "PENDING".
"After the occurrence of SARS-CoV-2 epidemic, different
laboratories in China have completed the isolation of virus
strains, and in order to make a big step forward in vaccine
development, we believe that we will soon have a final weapon
for the eradication of SARS-CoV-2, however, until now there is
no approved vaccine or drug for the treatment of CoV infection,
and there is a great need to develop an effective drug for the
treatment or prevention of coronavirus infection and outbreak."
Abstract
The invention belongs to the field of nano materials and
biomedicine, and relates to a vaccine, in particular to
development of 2019-nCoV coronavirus nuclear recombinant nano
vaccine. The invention also comprises a preparation method of
the vaccine and application of the vaccine in animal
experiments. The new corona vaccine contains graphene oxide,
carnosine, CpG and new corona virus RBD; binding carnosine, CpG
and neocoronavirus RBD on the backbone of graphene oxide; the
CpG coding sequence is shown as SEQ ID NO 1; the novel
coronavirus RBD refers to a novel coronavirus protein receptor
binding region which can generate a high-titer specific antibody
aiming at the RBD in a mouse body, and provides a strong support
for prevention and treatment of the novel coronavirus.
https://patents.google.com/patent/CN112220919A/en
===================================
CURRENT ASSIGNEE: Shanghai National Engineering Research Center
for Nanotechnology Co Ltd
https://www.companiess.com/shanghai_national_engineering_research_center_for_nanotechnology_co_ltd_info682279.html
===================================
Presence of graphene in Covid vaccines?
https://news4awake.wordpress.com/2021/08/23/presence-of-graphene-in-covid-vaccines/
===================================
DIRTY COVID VACCINES - Italian Study Reveals Prevalence of
Contaminants
https://justpaste.it/7rl1o